Copyright
©The Author(s) 2022.
World J Clin Cases. Nov 6, 2022; 10(31): 11313-11324
Published online Nov 6, 2022. doi: 10.12998/wjcc.v10.i31.11313
Published online Nov 6, 2022. doi: 10.12998/wjcc.v10.i31.11313
Figure 1 Patient recruitment, transjugular intrahepatic portosystemic stent-shunt, large volume paracentesis.
TIPSS: Transjugular intrahepatic portosystemic stent shunt; LVP: Large volume paracentesis.
Figure 2 Kaplan Meier graph.
A: Kaplan Meier graph of transplant-free survival for the whole cohort, (P = 0.30, log-rank); B: Kaplan Meier graph of transplant-free survival for propensity score-matched cohort, (P = 0.990, log-rank); C: Kaplan Meier graph of de-novo hepatic encephalopathy for the whole cohort, (P = 0.03, log-rank); D: Kaplan Meier graph of de novo hepatic encephalopathy for propensity score-matched cohort, (P < 0.029, log-rank). HE: Hepatic encephalopathy; TIPSS: Transjugular intrahepatic portosystemic stent shunt; LVP: Large volume paracentesis.
- Citation: Dhaliwal A, Merhzad H, Karkhanis S, Tripathi D. Covered transjugular intrahepatic portosystemic stent-shunt vs large volume paracentesis in patients with cirrhosis: A real-world propensity score-matched study. World J Clin Cases 2022; 10(31): 11313-11324
- URL: https://www.wjgnet.com/2307-8960/full/v10/i31/11313.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i31.11313